Challenges to antiretroviral therapy: can one sentence in medication labelling reduce adherence?

Dayani Galato University of Southern Santa Catarina, Research Group in Pharmaceutical Care and Studies on Drug Utilization (NAFEUM), Master Program in Health Sciences, Avenida José Acácio Moreira, 787 Bairro Dehon, Tubarão (SC), CEP 88704 900, Brazil+55 48 3621 3284; [email protected]

Anna Paula Piovezan University of Southern Santa Catarina, Research Group on Natural Products (GRUPNAT), Master Program in Health Sciences, Tubarão (SC), Brazil

"Challenges to antiretroviral therapy: can one sentence in medication labelling reduce adherence?." Expert Opinion on Pharmacotherapy, 12(17), pp. 2763–2764

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Challenges to antiretroviral therapy: can one sentence in medication labelling reduce adherence?

Information for

Open access

Opportunities

Help and information

Challenges to antiretroviral therapy: can one sentence in medication labelling reduce adherence?

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature